The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.
Jan 15, 2016
0
0
Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs.
Jan 5, 2016
0
1
Federal health authorities have approved a new drug that helps patients recover from the numbing effects of certain surgical drugs.
Dec 15, 2015
0
0
Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...
Nov 13, 2015
0
21
Merck's third-quarter profit more than doubled as heavy cost-cutting more than offset lower sales and the negative effects of a strong dollar.
Oct 27, 2015
0
4
Merck is recalling 276,000 bottles of a chemotherapy drug because the child-proof caps on the pill bottles may be cracked.
Aug 18, 2015
0
6
Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...
Apr 28, 2015
0
3
One of the hot new cancer immunotherapy drugs, Merck & Co.'s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three studies presented Sunday at the American Association for Cancer ...
Apr 19, 2015
0
10
Drugmaker Merck & Co.'s fourth-quarter profit skyrocketed to $7.32 billion, skewed by an $11.2 billion gain from selling its consumer health business to Germany's Bayer AG.
Feb 4, 2015
0
3
Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer.
Jan 12, 2015
0
4
